X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21016) 21016
Publication (1562) 1562
Newsletter (522) 522
Book Review (385) 385
Book Chapter (83) 83
Newspaper Article (59) 59
Magazine Article (56) 56
Conference Proceeding (24) 24
Dissertation (8) 8
Book / eBook (6) 6
Trade Publication Article (5) 5
Web Resource (2) 2
Government Document (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15030) 15030
male (9292) 9292
female (7999) 7999
index medicus (7763) 7763
middle aged (5820) 5820
animals (5609) 5609
aged (5151) 5151
stroke (4101) 4101
tissue plasminogen activator - administration & dosage (3907) 3907
thrombolytic therapy (3800) 3800
tissue plasminogen activator (3765) 3765
tissue plasminogen activator - therapeutic use (3538) 3538
treatment outcome (3506) 3506
adult (3480) 3480
thrombolysis (3467) 3467
peripheral vascular disease (3309) 3309
fibrinolytic agents - therapeutic use (2974) 2974
fibrinolytic agents - administration & dosage (2925) 2925
tissue-plasminogen activator (2892) 2892
clinical neurology (2753) 2753
time factors (2606) 2606
plasminogen-activator (2488) 2488
stroke - drug therapy (2482) 2482
aged, 80 and over (2046) 2046
neurosciences (2030) 2030
thrombolytic therapy - methods (2010) 2010
hematology (1967) 1967
therapy (1950) 1950
cardiac & cardiovascular systems (1908) 1908
mice (1887) 1887
acute ischemic-stroke (1865) 1865
fibrinolysis (1834) 1834
urokinase-type plasminogen activator - administration & dosage (1702) 1702
ischemia (1666) 1666
risk factors (1665) 1665
care and treatment (1655) 1655
myocardial infarction - drug therapy (1613) 1613
rats (1597) 1597
surgery (1546) 1546
research (1445) 1445
retrospective studies (1439) 1439
thrombosis (1346) 1346
brain ischemia - drug therapy (1303) 1303
analysis (1298) 1298
tissue-plasminogen-activator (1285) 1285
urokinase (1284) 1284
pharmacology & pharmacy (1275) 1275
tissue plasminogen activator - adverse effects (1266) 1266
neurology (1244) 1244
infusions, intravenous (1184) 1184
disease models, animal (1182) 1182
health aspects (1176) 1176
mortality (1173) 1173
urokinase-type plasminogen activator - therapeutic use (1167) 1167
alteplase (1159) 1159
prospective studies (1128) 1128
acute myocardial-infarction (1120) 1120
acute disease (1113) 1113
fibrinolytic agents - adverse effects (1090) 1090
drug therapy (1059) 1059
trial (1051) 1051
plasminogen-activator inhibitor-1 (991) 991
dose-response relationship, drug (981) 981
medicine & public health (966) 966
fibrinolysis - drug effects (941) 941
thrombolytic therapy - adverse effects (931) 931
stroke - therapy (919) 919
expression (897) 897
management (889) 889
medicine, general & internal (889) 889
hemorrhage (880) 880
thrombosis - drug therapy (878) 878
recombinant proteins - administration & dosage (860) 860
article (851) 851
drug therapy, combination (844) 844
inflammation (834) 834
prognosis (830) 830
recombinant proteins - therapeutic use (824) 824
follow-up studies (816) 816
streptokinase (799) 799
injections, intravenous (771) 771
reperfusion (771) 771
adolescent (730) 730
stroke - diagnosis (728) 728
biochemistry & molecular biology (725) 725
tomography, x-ray computed (723) 723
radiology, nuclear medicine & medical imaging (715) 715
plasminogen activators - therapeutic use (694) 694
oncology (682) 682
tissue plasminogen-activator (680) 680
plasminogen activator inhibitor 1 - blood (672) 672
brain (669) 669
intravenous thrombolysis (667) 667
streptokinase - therapeutic use (664) 664
ischemic stroke (662) 662
thrombolytic drugs (648) 648
mice, inbred c57bl (640) 640
plasminogen activators - administration & dosage (632) 632
heparin (629) 629
recurrence (621) 621
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20489) 20489
Japanese (328) 328
German (293) 293
French (150) 150
Chinese (101) 101
Russian (73) 73
Spanish (71) 71
Italian (58) 58
Polish (32) 32
Danish (20) 20
Czech (16) 16
Norwegian (16) 16
Hungarian (14) 14
Dutch (11) 11
Portuguese (11) 11
Korean (9) 9
Swedish (6) 6
Turkish (6) 6
Hebrew (3) 3
Finnish (2) 2
Serbian (2) 2
Icelandic (1) 1
Romanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Stroke, ISSN 0039-2499, 07/2006, Volume 37, Issue 7, pp. 1822 - 1827
Background and Purpose-Systemic thrombolysis is the only therapy proven to be effective for ischemic stroke. Telemedicine may help to extend its use. However,... 
Telemedicine | Thrombolysis | Stroke | INTRAVENOUS THROMBOLYSIS | MORTALITY | telemedicine | ECASS | COOPERATIVE ACUTE STROKE | T-PA | stroke | CLINICAL NEUROLOGY | ALTEPLASE | ACUTE ISCHEMIC-STROKE | thrombolysis | PERIPHERAL VASCULAR DISEASE | EXPERIENCE | THROMBOLYTIC THERAPY | CLINICAL-PRACTICE | Recombinant Proteins - therapeutic use | Prospective Studies | Humans | Middle Aged | Remote Consultation - organization & administration | Hypertension - drug therapy | Male | Tomography, X-Ray Computed | Tissue Plasminogen Activator - therapeutic use | Recombinant Proteins - adverse effects | Tissue Plasminogen Activator - adverse effects | Computer Communication Networks - statistics & numerical data | Fibrinolytic Agents - adverse effects | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy - methods | Aged, 80 and over | Adult | Female | Hospital Departments | Cerebral Hemorrhage - chemically induced | Internal Medicine | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Hospitals, Community - organization & administration | Antihypertensive Agents - therapeutic use | Case Management - organization & administration | Computer Communication Networks - organization & administration | Recombinant Proteins - administration & dosage | Magnetic Resonance Imaging | Pilot Projects | Brain Ischemia - drug therapy | Catchment Area (Health) | Brain Ischemia - pathology | Hypertension - complications | Aged | Fibrinolytic Agents - administration & dosage | Academic Medical Centers - organization & administration | Thrombolytic Therapy - adverse effects | Brain Ischemia - diagnostic imaging | Germany | Patient Transfer
Journal Article
Annals of Emergency Medicine, ISSN 0196-0644, 2016, Volume 68, Issue 3, pp. 345 - 348
Journal Article
Journal Article
American Journal of Emergency Medicine, ISSN 0735-6757, 08/2019, Volume 37, Issue 8, pp. 1602.e5 - 1602.e6
The risk of tPA in the treatment of stroke, is that approximately 5% of patients may have significant intracranial bleeding, increasing mortality to 45%. Use... 
Tranexamic acid | Stroke | Pulmonary hemorrhage | Intubation | Tissue plasminogen activator | EMERGENCY MEDICINE | INTRACEREBRAL HEMORRHAGE | Stroke (Disease) | Emergency medicine | Mortality | Respiratory agents | Health aspects | Hemorrhage | Respiratory tract | Acids | Complications | Drug therapy | Patients | Bleeding | t-Plasminogen activator
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9834, pp. 2352 - 2363
Journal Article